Key Points
- Insider sale: Director Dennis Suskind sold 748 shares at an average of $300 on Feb. 6 for $224,400, reducing his stake by 21.7% to 2,699 shares, a transaction disclosed in an SEC Form 4 and viewed by some investors as a modest negative signal.
- Operational and market context: CME beat Q results (EPS $2.77 vs. $2.75) with revenue up 8.1% to $1.65B and a ~62.5% net margin, while institutional demand (Intermede’s ~ $77.8M new position) and FlexTrade’s integration of CME FX products support growth despite a consensus "Hold" rating and $297.59 price target.
CME Group Inc. (NASDAQ:CME - Get Free Report) Director Dennis Suskind sold 748 shares of the firm's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director directly owned 2,699 shares of the company's stock, valued at approximately $809,700. The trade was a 21.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
CME Group Stock Up 1.6%
Shares of CME opened at $307.24 on Tuesday. The company has a market capitalization of $110.79 billion, a P/E ratio of 27.53, a PEG ratio of 3.29 and a beta of 0.27. CME Group Inc. has a one year low of $239.70 and a one year high of $307.84. The business's 50 day simple moving average is $277.46 and its 200-day simple moving average is $273.21. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating analysts' consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm had revenue of $1.65 billion during the quarter, compared to analysts' expectations of $1.64 billion. During the same period last year, the firm posted $2.52 EPS. The business's revenue was up 8.1% on a year-over-year basis. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.
Wall Street Analyst Weigh In
CME has been the topic of several research reports. Bank of America upped their price target on shares of CME Group from $201.00 to $209.00 in a research report on Wednesday, December 10th. Piper Sandler upped their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an "overweight" rating in a research report on Thursday, November 13th. Raymond James Financial decreased their price target on shares of CME Group from $311.00 to $310.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 4th. TD Cowen raised their price target on shares of CME Group from $305.00 to $328.00 and gave the company a "buy" rating in a report on Thursday. Finally, The Goldman Sachs Group upped their price objective on CME Group from $264.00 to $266.00 and gave the stock a "sell" rating in a report on Monday. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $297.59.
Read Our Latest Report on CME
Trending Headlines about CME Group
Here are the key news stories impacting CME Group this week:
Institutional Trading of CME Group
Institutional investors and hedge funds have recently made changes to their positions in the business. Caldwell Trust Co increased its holdings in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider's stock valued at $25,000 after purchasing an additional 50 shares during the last quarter. Asset Dedication LLC grew its position in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock worth $26,000 after buying an additional 37 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA bought a new stake in shares of CME Group in the 3rd quarter valued at about $27,000. FNY Investment Advisers LLC acquired a new stake in shares of CME Group in the 4th quarter valued at approximately $27,000. Finally, Financial Consulate Inc. bought a new position in CME Group during the 3rd quarter worth approximately $28,000. Institutional investors own 87.75% of the company's stock.
CME Group Company Profile
(
Get Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
